News
Cannabidiol (CBD) and cannabigerol (CBG) are increasingly studied for their therapeutic applications in neurological and vision-related conditions. While lower doses (20–300 mg/day) are effective for mild to moderate symptoms, emerging research suggests high doses (600–1000 mg/day) may provide amplified benefits for certain conditions. Let’s dive into the science supporting these high-dose treatments and their specific applications.
Continue reading
Living with Parkinson’s comes with daily challenges, from muscle stiffness and tremors to sleep disturbances and discomfort. But could nature hold a key to relief? Emerging research suggests that cannabinoids—especially CBG, CBN, and full-spectrum extracts—may offer neuroprotective benefits, help ease dyskinesia and even promote better sleep. Topical cannabinoid products might also provide targeted relief for muscle tension and discomfort. With studies showing promising results, it’s time to explore whether these plant-based compounds could make a real difference. Read on to uncover the science behind cannabinoids and their potential role in Parkinson’s care
